Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

JAMA - 19 Jun 2013

Ziegler Anette G, Rewers Marian, Simell Olli, Simell Tuula, Lempainen Johanna, Steck Andrea, Winkler Christiane, Ilonen Jorma, Veijola Riitta, Knip Mikael, Bonifacio Ezio, Eisenbarth George S

Abstract excerpt

IMPORTANCE: Type 1 diabetes usually has a preclinical phase identified by circulating islet autoantibodies, but the rate of progression to diabetes after seroconversion to islet autoantibodies is uncertain. OBJECTIVE: To determine the rate of progression to diabetes after islet autoantibody seroconversion. DESIGN, SETTING, AND PARTICIPANTS: Data were pooled from prospective cohort studies performed in Colorado...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Colorado

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Finland

Share to Germany

Share to Glutamate Decarboxylase

Share to Insulin

Share to Islets of Langerhans

Source

Open in PubMed Open full text

Identifiers

PMID: 23780460
DOI: 10.1001/jama.2013.6285
PMCID: PMC4878912

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.PMID 23780460Read ↗

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesSemantic proximity Read ↗

Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.Semantic proximity Read ↗

Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes.Semantic proximity Read ↗

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).Semantic proximity Read ↗

Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).Semantic proximity Read ↗

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.Semantic proximity Read ↗

Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.Semantic proximity Read ↗

Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.Semantic proximity Read ↗

Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age.Semantic proximity Read ↗

Predictors of slow progression to diabetes in children with multiple islet autoantibodies.Semantic proximity Read ↗

Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.Semantic proximity Read ↗

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.